Filter Results:
(1,353)
Show Results For
- All HBS Web
(1,353)
- People (1)
- News (339)
- Research (774)
- Events (3)
- Multimedia (36)
- Faculty Publications (483)
Show Results For
- All HBS Web
(1,353)
- People (1)
- News (339)
- Research (774)
- Events (3)
- Multimedia (36)
- Faculty Publications (483)
- May 24, 2016
- Article
Build a Culture of Health
By: John A. Quelch
Every company, large and small, has an impact on health. It does so in four ways: first, through the healthfulness and safety of the products and services it sells; second, through its attention to employee health and well-being in its work practices and benefits;... View Details
Keywords: Public Health; Four Pillars; Public Health Footprint; Culture Of Health Plan Of Action; Change; Education; Health; Human Resources; Knowledge; Labor; Leadership; Management; Operations; Outcome or Result; Personal Development and Career; Programs; Risk and Uncertainty; Strategy; Value; Consumer Products Industry; Chemical Industry; Health Industry; United States; Europe
Quelch, John A. "Build a Culture of Health." Huffington Post: What's Working: Purpose + Profit (May 24, 2016).
- Research Summary
Optimal Signaling Policy with Rational and Irrational Agents (with James Burns)
We examine situations in which a single informed agent signals a group of uniformed agents. The uniformed agents must then take an action based on this signal. The motivation for our work comes from real world examples such as terrorist alerts or job safety... View Details
- 12 PM – 1 PM EST, 13 Dec 2016
- Webinars: Trending@HBS
Buying a Small Business: How to Take Advantage of Big Opportunities
There are over 1 million smaller firms in North America and each year thousands and thousands come up for sale, principally as founders retire. Acquiring the right kind of smaller firm offers very compelling economic rewards, and you can become CEO of one of these... View Details
- 25 May 2020
- News
For Kenny Chesney and Others, Promotion in a Pandemic Is a Quandary
- 2009
- Working Paper
Integrity: Without It Nothing Works
By: Michael C. Jensen
There is confusion between integrity, morality and ethics. In our much longer paper on the topic (see "Integrity: A Positive Model that Incorporates the Normative Phenomena of Morality, Ethics and Legality" (available at http://ssrn.com/abstract=920625)) my co-authors,... View Details
- 05 Apr 2022
- News
Building Fearless Organizations with Amy Edmondson
- 2023
- Book
Right Kind of Wrong: The Science of Failing Well
By: Amy Edmondson
A revolutionary guide that will transform your relationship with failure, from the pioneering researcher of psychological safety and award-winning Harvard Business School professor Amy Edmondson.
We used to think of failure as the opposite of success. Now,... View Details
We used to think of failure as the opposite of success. Now,... View Details
Edmondson, Amy. Right Kind of Wrong: The Science of Failing Well. New York, NY: Atria Books, 2023.
- February 1994 (Revised May 1999)
- Case
Manville Corp. Fiber Glass Group (C)
By: Lynn S. Paine and Sarah Gant
Manville Corp.'s senior managers are surprised when Japanese government officials advise them not to go forward with their plan to add a cancer warning label to diatomaceous earth (DE) products sold in Japan. The International Agency for Research on Cancer has ruled... View Details
Keywords: Management Teams; Ethics; Conflict of Interests; Health; Safety; Cross-Cultural and Cross-Border Issues; Policy; Japan
Paine, Lynn S., and Sarah Gant. "Manville Corp. Fiber Glass Group (C)." Harvard Business School Case 394-116, February 1994. (Revised May 1999.)
- August 2008 (Revised September 2008)
- Case
The Flaxil Label (A)
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Product Launch; Negotiation Process; Business and Government Relations; Safety; Pharmaceutical Industry
Barron, Greg M. "The Flaxil Label (A)." Harvard Business School Case 909-001, August 2008. (Revised September 2008.)
- March 2018 (Revised May 2018)
- Case
Celgene
By: Malcolm Baker and Emily McComb
In February 2011, Adam Koppel, a managing director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm’s position in Celgene Corporation. News has emerged that raises potential safety concerns associated with... View Details
Keywords: Life Sciences; Biotechnology; Public Market Investing; Celgene; Revlimid; Hedge Fund; Growth Stocks; Valuation; Investment; Decision Choices and Conditions; Analysis; Biotechnology Industry
Baker, Malcolm, and Emily McComb. "Celgene." Harvard Business School Case 218-094, March 2018. (Revised May 2018.)
- 01 Dec 2021
- News
18 Books Every Business Leader Should Read
- 15 Apr 2020
- News
Creating a Fearless Organization With Amy Edmondson
- 15 Nov 2018
- News
Dysfunctional Teams
- May 2016 (Revised October 2016)
- Case
Agricultural Revolution without a Land Revolution: the Megafarms of CP Group
By: William C. Kirby and Nancy Hua Dai
This case describes the megafarm model launched by the CP group as part of their efforts to ensure the safety and quality of their supply chain of agricultural products (particularly, eggs) in China while also promoting the welfare of Chinese farmers. This model was... View Details
Keywords: China; Poultry; Public-private Partnership; Animal-Based Agribusiness; Family Business; Agriculture and Agribusiness Industry; China
Kirby, William C., and Nancy Hua Dai. "Agricultural Revolution without a Land Revolution: the Megafarms of CP Group." Harvard Business School Case 316-150, May 2016. (Revised October 2016.)
- October 2018 (Revised September 2020)
- Case
Testing Autonomy in Pittsburgh
By: Mitchell Weiss and Brittany Urick
Pittsburgh’s mayor had been among the first to welcome self-driving vehicles but was now one of many needing to react after a pedestrian fatality involving an autonomous Uber in Arizona. He had originally preferred to roll out “the red carpet” instead of the “red... View Details
Keywords: Public Entrepreneurship; Government Innovation; Government Experimentation; Autonomous Vehicles; Mayor; Mayor Peduto; Cities; Mobility; Automation; Uber; Argo Ai; Aurora Innovation; Aptiv; Entrepreneurship; Public Sector; Innovation and Invention; Transportation; City; Safety; Business and Government Relations; Transportation Industry; Auto Industry; United States; Pennsylvania; Pittsburgh
Weiss, Mitchell, and Brittany Urick. "Testing Autonomy in Pittsburgh." Harvard Business School Case 819-059, October 2018. (Revised September 2020.)
- April 2018
- Supplement
Celgene
By: Malcolm Baker and Emily R. McComb
In February 2011, Adam Koppel, a Managing Director at Brookside Capital, the public equity arm of Bain Capital, must decide whether to increase or exit the firm’s position in Celgene Corporation. News has emerged that raises potential safety concerns associated with... View Details